Clinical Trials Browser

NCT07472140 2026-03-16

PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal Cancer

Phase 2/3 Recruiting

120 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT07362147 2026-01-23

Exploring the Effects of Hand and Foot Exercise Intervention in Older Adults With Gynecological Cancer Receiving Chemotherapy Improvement of Peripheral Neuropathy and Quality of Life

Phase NA Not yet recruiting

74 enrolled

Gynecologic

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peripheral Nervous System Diseases, Vaginal Neoplasms, Endometrial Neoplasms

NCT05236686 2025-11-19

Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer

Phase NA Recruiting

94 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Lymphatic Metastasis, Ovarian Neoplasms

NCT07154966 2025-09-04

GYM-TASTE

Completed

102 enrolled

Gynecologic

Dysgeusia, Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Malnutrition, Sarcopenia

NCT06602063 2025-06-27

Surgery for Relapsed Ovarian Cancer in Precision

Phase 1/2 Not yet recruiting

33 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06846424 2025-02-26

SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer

Phase 1 Not yet recruiting

24 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02859038 2025-02-10

Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY)

Phase 3 Active not recruiting

489 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT05200260 2025-02-10

Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer

Phase 2 Recruiting

220 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01276574 2024-12-04

Mupet

Active not recruiting

150 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03983226 2022-03-18

Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)

Phase 2 Recruiting

167 enrolled

Gynecologic

Fallopian Tube Neoplasms

NCT01611766 2021-06-10

Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)?

Phase 3 Unknown

356 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

NCT04515602 2020-08-27

FOCUS

Phase 3 Not yet recruiting

410 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT03150121 2020-02-26

BEDOCA

Phase NA Unknown

500 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Cystadenocarcinoma, Serous

NCT04001023 2019-08-07

OVANOX

Phase NA Unknown

40 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Hypoxia, Fallopian Tube Neoplasms

NCT01669226 2016-12-19

AICE

Phase 2 Completed

215 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02595021 2016-07-26

Total/Subtotal Colectomy in Ovarian Cancer

Phase 2 Unknown

80 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00532194 2015-09-23

ICON6

Phase 3 Unknown

486 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00850772 2014-06-12

OPEN

Phase 3 Completed

109 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Malnutrition

NCT01654146 2012-07-31

ICON8

Phase 3 Unknown

1,485 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms